targeted treatment of the rheumatic diseases: expert consult
Targeted Treatment of the Rheumatic Diseases: Expert Consult
$168.00 Original price was: $168.00.$4.99Current price is: $4.99. Add to cart
Sale!

Targeted Treatment of the Rheumatic Diseases: Expert Consult

Original price was: $168.00.Current price is: $4.99.

-97%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Biologic Arsenal: Targeted Treatment of the Rheumatic Diseases: Expert Consult

Rheumatology is no longer a specialty of managing inevitable decline and permanent joint deformities. With the invention of targeted biologics, it is now a specialty capable of delivering complete, miraculous disease remission. Targeted Treatment of the Rheumatic Diseases: Expert Consult is the definitive, fiercely advanced scientific guide to deploying the most powerful drugs in modern medicine. For board-certified rheumatologists and clinical immunologists, this massive volume provides the uncompromising blueprints required to perfectly match a highly toxic, genetically engineered drug to a specific patient’s failing immune system.

The Evolution of Precision Immunology

The core philosophy of this textbook is absolute molecular targeting. The authors aggressively detail the shift away from broad, carpet-bombing chemotherapy (like Methotrexate) toward absolute precision strikes. The text exhaustively details the exact protein structures of these drugs, explaining how a massive monoclonal antibody physically binds to and neutralizes a single, specific inflammatory cytokine (like TNF-alpha or IL-17) floating in the patient’s blood.

Matching the Patient Phenotype to the Perfect Biologic

This is a fiercely practical guide to personalized medicine. The authors do not just list the drugs; they provide the exact algorithms for selecting them. They detail the extreme clinical nuance required to decide between using a B-cell depleting agent (Rituximab) for a patient with Rheumatoid Arthritis and a history of lymphoma, versus a T-cell costimulation modulator (Abatacept) for a patient with severe, refractory disease.

Managing Refractory Rheumatoid Arthritis and Lupus

The core of the manual provides a masterclass in salvaging failing patients. The authors dedicate massive sections to the terrifying reality of “refractory” disease—when the patient’s immune system mutates and learns how to overcome the biologic drug. The text details the exact pharmacological protocols for recognizing anti-drug antibodies, and the rigid strategies required to switch the patient to an entirely new class of biologic (e.g., from a TNF inhibitor to a JAK inhibitor) to regain control.

Predicting and Preventing Severe Opportunistic Infections

The book pushes heavily into risk management. These drugs are miraculous, but they deliberately suppress the immune system. The authors provide the exact, mandatory screening protocols required before initiating therapy. They detail exactly how to monitor patients for terrifying opportunistic infections, fungal pneumonias, and the catastrophic reactivation of latent Tuberculosis or Hepatitis B.

The Economics and Logistics of Long-Term Infusions

The final value of this reference is its focus on the real-world logistics of biologic therapy. The authors provide exhaustive guidance on managing the infusion center, treating severe anaphylactic infusion reactions in real-time, and navigating the massive financial and insurance hurdles required to keep a patient on a ,000-per-year medication.

Frequently Asked Questions (FAQs)

Does this book cover pediatric biologic dosing?
Yes, it features critical sections on the use of targeted therapies in severe Juvenile Idiopathic Arthritis (JIA) and pediatric lupus, where the margin for error is microscopic.

Is this a general textbook covering how to diagnose arthritis?
No. This is an advanced therapeutics manual. It assumes the diagnosis has already been made and focuses entirely on the advanced pharmacological algorithms required to treat it.

Who is the primary audience?
It is the absolute, mandatory desk reference for board-certified Rheumatologists, Clinical Immunology Pharmacists, and advanced practitioners managing biologic infusion centers.

Conclusion

Targeted Treatment of the Rheumatic Diseases proves that autoimmune diseases can be mathematically dismantled at the molecular level. It is an indispensable guide to utilizing the ultimate biologic arsenal. By mastering the receptor mechanics, the strict infection screening protocols, and the complex switching algorithms detailed in this volume, specialists can deliver miraculous, life-changing remissions to patients suffering from paralyzing inflammatory diseases.